These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 16483458

  • 41. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
    Freitag FG, Finlayson G, Rapoport AM, Elkind AH, Diamond ML, Unger JR, Fisher AC, Armstrong RB, Hulihan JF, Greenberg SJ, AIMS Investigators.
    Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
    [Abstract] [Full Text] [Related]

  • 42. Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine.
    Silberstein SD, Mannix LK, Goldstein J, Couch JR, Byrd SC, Ames MH, McDonald SA, Lener SE, Toso C.
    Neurology; 2008 Jul 08; 71(2):114-21. PubMed ID: 18606965
    [Abstract] [Full Text] [Related]

  • 43. "TIA" or migraine in a woman with no risk factors for cerebral vascular disease.
    Heidenreich WF.
    J Insur Med; 2008 Jul 08; 40(3-4):234-9. PubMed ID: 19317333
    [Abstract] [Full Text] [Related]

  • 44. Premonitory Symptoms in Episodic and Chronic Migraine From a Pediatric Headache Clinic.
    Jacobs H, Pakalnis A.
    Pediatr Neurol; 2019 Aug 08; 97():26-29. PubMed ID: 31076200
    [Abstract] [Full Text] [Related]

  • 45. Biological insights from the premonitory symptoms of migraine.
    Karsan N, Goadsby PJ.
    Nat Rev Neurol; 2018 Dec 08; 14(12):699-710. PubMed ID: 30448858
    [Abstract] [Full Text] [Related]

  • 46. The premonitory phase of migraine--what can we learn from it?
    Maniyar FH, Sprenger T, Monteith T, Schankin CJ, Goadsby PJ.
    Headache; 2015 May 08; 55(5):609-20. PubMed ID: 25919990
    [Abstract] [Full Text] [Related]

  • 47. [Proinflammatory cytokines in children with idiopathic headache].
    Gergont A, Kaciński M, Kwinta P.
    Przegl Lek; 2005 May 08; 62(11):1269-75. PubMed ID: 16512619
    [Abstract] [Full Text] [Related]

  • 48. Allodynia and migraine.
    Aguggia M.
    Neurol Sci; 2012 May 08; 33 Suppl 1():S9-11. PubMed ID: 22644161
    [Abstract] [Full Text] [Related]

  • 49. Efficacy of Rizatriptan 10 mg administered early in a migraine attack.
    Cady R, Martin V, Mauskop A, Rodgers A, Hustad CM, Ramsey KE, Skobieranda F.
    Headache; 2006 Jun 08; 46(6):914-24. PubMed ID: 16732837
    [Abstract] [Full Text] [Related]

  • 50. The triggers or precipitants of the acute migraine attack.
    Kelman L.
    Cephalalgia; 2007 May 08; 27(5):394-402. PubMed ID: 17403039
    [Abstract] [Full Text] [Related]

  • 51. Is migraine a disease?
    Cortelli P, Pierangeli G, Montagna P.
    Neurol Sci; 2010 Jun 08; 31 Suppl 1():S29-31. PubMed ID: 20464579
    [Abstract] [Full Text] [Related]

  • 52. The Sinus, Allergy and Migraine Study (SAMS).
    Eross E, Dodick D, Eross M.
    Headache; 2007 Feb 08; 47(2):213-24. PubMed ID: 17300361
    [Abstract] [Full Text] [Related]

  • 53. Dopamine involvement in the migraine attack.
    Fanciullacci M, Alessandri M, Del Rosso A.
    Funct Neurol; 2000 Feb 08; 15 Suppl 3():171-81. PubMed ID: 11200788
    [Abstract] [Full Text] [Related]

  • 54. Brainstem auditory-evoked potential habituation and intensity-dependence related to serotonin metabolism in migraine: a longitudinal study.
    Sand T, Zhitniy N, White LR, Stovner LJ.
    Clin Neurophysiol; 2008 May 08; 119(5):1190-200. PubMed ID: 18316245
    [Abstract] [Full Text] [Related]

  • 55. A Phase-by-Phase Review of Migraine Pathophysiology.
    Dodick DW.
    Headache; 2018 May 08; 58 Suppl 1():4-16. PubMed ID: 29697154
    [Abstract] [Full Text] [Related]

  • 56. Visual evoked potential latency, amplitude and habituation in migraine: a longitudinal study.
    Sand T, Zhitniy N, White LR, Stovner LJ.
    Clin Neurophysiol; 2008 May 08; 119(5):1020-7. PubMed ID: 18308628
    [Abstract] [Full Text] [Related]

  • 57. Slow cortical potentials in migraine. Predictive value and possible novel therapeutic strategies to prevent an attack.
    Kropp P, Gerber WD.
    Funct Neurol; 2005 May 08; 20(4):193-7. PubMed ID: 16483460
    [Abstract] [Full Text] [Related]

  • 58. Can migraineurs accurately identify their headaches as "migraine" at attack onset?
    Ng-Mak DS, Cady R, Chen YT, Ma L, Bell CF, Hu XH.
    Headache; 2007 May 08; 47(5):645-53. PubMed ID: 17501845
    [Abstract] [Full Text] [Related]

  • 59. Symptoms of migraine in the paediatric population by age group.
    Eidlitz-Markus T, Gorali O, Haimi-Cohen Y, Zeharia A.
    Cephalalgia; 2008 Dec 08; 28(12):1259-63. PubMed ID: 18727643
    [Abstract] [Full Text] [Related]

  • 60. A clinical study of migraine evolution.
    Pryse-Phillips W, Aubé M, Bailey P, Becker WJ, Bellavance A, Gawel M, Giammarco R, Mackie G, Purdy RA, Robinson G, Shapero G, Wilson K.
    Headache; 2006 Dec 08; 46(10):1480-6. PubMed ID: 17115980
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.